The study also found that cell viability in the presence of...

The study also found that cell viability in the presence of IMM-124E “was greatly enhanced” compared to the placebo.“We know that SARS-CoV-2 causes an influenza-like disease that is primarily thought to infect the lungs with transmission through the respiratory route ranging from mild respiratory symptoms to severe lung injury, multi-organ failure and death,” Immuron chief executive officer Dr Jerry Kanellos said.“Respiratory symptoms have dominated the clinical focus, however, gastrointestinal symptoms such as diarrhea, vomiting and abdominal pain are also observed in a growing subset of patients often presenting with no respiratory symptoms.”Dr Kanellos added that the symptoms were updated recently in the US to include diarrhea and that there was mounting evidence the virus is also targeting the gastrointestinal tract.